Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissues
Authors:
- K.M. RobersonKRK.M. Roberson
- A.J. HerzbergAHA.J. Herzberg
- B.-J.M. KernsBKB.-J.M. Kerns
- R.K. DodgeRDR.K. Dodge
- D.F. PaulsonDPD.F. Paulson
- 31 August 1994
- journal article
- research article
- Published by Elsevier in Surgical Oncology
- Vol. 3 (4) , 237-242
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Differential Immunoreactivity of Epidermal Growth Factor Receptor in Benign, Dysplastic and Malignant Prostatic TissuesJournal of Urology, 1993
- Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway.Journal of Cell Biology, 1986
- Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes.Proceedings of the National Academy of Sciences, 1984
- Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth FactorScience, 1984
- Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor.Proceedings of the National Academy of Sciences, 1983
- The role of protein phosphorylation in neural and hormonal control of cellular activityNature, 1982
- A monoclonal antibody to the human epidermal growth factor receptorJournal of Cellular Biochemistry, 1982
- Accumulation of epidermal growth factor within cells does not depend on receptor recyclingBiochemical and Biophysical Research Communications, 1980
- Epidermal Growth FactorAnnual Review of Biochemistry, 1979
- Epidermal growth factor stimulates phosphorylation in membrane preparations in vitroNature, 1978